Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
The wash sale rule can impact tax planning for index funds; understand the rules to avoid unwanted consequences.
15,383 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A major share sale spooked investors and pushed Brightstar Lottery stock down. This guide breaks down what happened, ...
As downsizing gains pace, a hidden Medicare surcharge could erase gains from selling the family home. Here’s what ret...
A 64-year-old single restaurant owner selling a $1.2 million business discovers 1031 rules won’t cover all gains; a t...
When a CFO sells a sizable chunk of stock, it can raise questions about the company's outlook. This guide breaks down...
When a high-level insider trims a stake, it can spark questions about a company’s near-term prospects. This article b...
Insider moves can shape sentiment, but they aren’t a stand-alone signal. This deep dive explains what c3.ai's sold 17...
When a Lincoln Educational director sold a sizable block of shares, investors took note. This article breaks down the...
A Tuya insider sale by tuya director sidney xuande drew market attention. This article explains what the move signals...
An executive chair's sizable stock sale draws attention. This piece explains what the numbers mean, how to read insid...
A large 2024 capital gain can trigger IRMAA surcharges, causing Medicare premiums to surge in 2026. Retirees face hun...
A simple, low-cost two-fund approach using Vanguard MID- and SMALL-CAP ETFs may offer upside versus the S&P 500 over ...